Ghisallo Capital Management LLC trimmed its position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 50.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 50,000 shares of the company's stock after selling 50,000 shares during the period. Ghisallo Capital Management LLC owned about 0.08% of Guardian Pharmacy Services worth $1,013,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of GRDN. Barclays PLC purchased a new position in shares of Guardian Pharmacy Services during the 3rd quarter valued at about $311,000. Virtu Financial LLC purchased a new position in shares of Guardian Pharmacy Services during the 3rd quarter valued at about $279,000. Franklin Resources Inc. purchased a new position in shares of Guardian Pharmacy Services during the 3rd quarter valued at about $8,575,000. Investment Research & Advisory Group Inc. purchased a new position in shares of Guardian Pharmacy Services during the 4th quarter valued at about $34,000. Finally, R Squared Ltd purchased a new position in shares of Guardian Pharmacy Services during the 4th quarter valued at about $30,000.
Analysts Set New Price Targets
Separately, Truist Financial raised their price objective on Guardian Pharmacy Services from $24.00 to $25.00 and gave the company a "buy" rating in a report on Friday, April 11th.
View Our Latest Stock Report on Guardian Pharmacy Services
Guardian Pharmacy Services Trading Down 0.7 %
GRDN traded down $0.18 during trading on Thursday, hitting $24.86. 41,521 shares of the stock traded hands, compared to its average volume of 84,088. The firm has a 50-day moving average of $21.27 and a 200 day moving average of $21.15. Guardian Pharmacy Services, Inc. has a 12-month low of $14.16 and a 12-month high of $25.89.
About Guardian Pharmacy Services
(
Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Featured Stories

Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.